These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 938940)
21. Hypothyroidism inhibits the formation of inositol phosphate in response to carbachol in the striatum of adult rat. Iriuchijima T; Michimata T; Mizuma H; Murakami M; Yamada M; Mori M Res Commun Chem Pathol Pharmacol; 1991 Aug; 73(2):173-80. PubMed ID: 1784833 [TBL] [Abstract][Full Text] [Related]
22. Neurochemical aspects of the ontogenesis of cholinergic neurons in the rat brain. Coyle JT; Yamamura HI Brain Res; 1976 Dec; 118(3):429-40. PubMed ID: 1009427 [TBL] [Abstract][Full Text] [Related]
23. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization. Luthin GR; Wolfe BB Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291 [TBL] [Abstract][Full Text] [Related]
24. Structure and conformation activity relationships of heterocyclic acetylcholine analogues. X. The inhibitory effect of 3-quinuclidinyl benzilates on cardiac muscarinic receptors. Lambrecht G Arzneimittelforschung; 1980; 30(12):2113-5. PubMed ID: 7194070 [TBL] [Abstract][Full Text] [Related]
25. Age-related differences in brain choline acetyltransferase, cholinesterases and muscarinic receptor sites in two strains of rats. Michalek H; Fortuna S; Pintor A Neurobiol Aging; 1989; 10(2):143-8. PubMed ID: 2725809 [TBL] [Abstract][Full Text] [Related]
26. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain. Luthin GR; Wolfe BB J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770 [TBL] [Abstract][Full Text] [Related]
27. Supersensitivity of the cholinergic muscarinic system in the rat's brain is induced by high concentrations of Cu+2. Gutiérrez-Reyes E; Castañeda-Perozo D; Papale-Centofanti J; Nello-Pérez C; Pascuzzo-Lima C; Moreno-Yanez J; Bonfante-Cabarcas R Invest Clin; 2002 Jun; 43(2):107-17. PubMed ID: 12108025 [TBL] [Abstract][Full Text] [Related]
28. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes. Burke RE Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217 [TBL] [Abstract][Full Text] [Related]
29. Neuronal function impairment in rabies-infected rat brain. Tsiang H J Gen Virol; 1982 Aug; 61 (Pt 2)():277-81. PubMed ID: 7119753 [TBL] [Abstract][Full Text] [Related]
30. Increased number of muscarinic binding sites in brain following chronic barbiturate treatment to rat. Nordberg A; Wahlström G; Larsson C Life Sci; 1980 Jan; 26(3):231-7. PubMed ID: 7189007 [No Abstract] [Full Text] [Related]
31. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart. Luthin GR; Harkness J; Artymyshyn RP; Wolfe BB Mol Pharmacol; 1988 Sep; 34(3):327-33. PubMed ID: 3419425 [TBL] [Abstract][Full Text] [Related]
32. Muscarinic cholinergic binding in rat brain. Yamamura HI; Snyder SH Proc Natl Acad Sci U S A; 1974 May; 71(5):1725-9. PubMed ID: 4151898 [TBL] [Abstract][Full Text] [Related]
33. Atropine-amitriptyline interactions in the rat central cholinergic nervous system. Goldman ME; Erickson CK Brain Res; 1982 Sep; 248(1):188-91. PubMed ID: 7127138 [No Abstract] [Full Text] [Related]
34. Interaction of the neuromuscular blocking drug atracurium with muscarinic acetylcholine receptors. Musílková J; Starshinova LA; Shelkovnikov SA; Tucek S Physiol Res; 1991; 40(3):293-304. PubMed ID: 1751476 [TBL] [Abstract][Full Text] [Related]
35. Postsynaptic localization of muscarinic cholinergic receptor binding in rat hippocampus. Yamamura HI; Snyder SH Brain Res; 1974 Sep; 78(2):320-6. PubMed ID: 4853717 [No Abstract] [Full Text] [Related]
36. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport. Zimmerman TW; Binder HJ Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277 [TBL] [Abstract][Full Text] [Related]
37. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats. Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of in vivo binding properties of 3H-NMPB and 3H-QNB in mouse brain. Hosoi R; Kobayashi K; Watanabe Y; Inoue O J Neural Transm (Vienna); 1999; 106(7-8):583-92. PubMed ID: 10907719 [TBL] [Abstract][Full Text] [Related]
39. Microanalysis of amino acids in small regions of the rat brain using dansyl chloride. Leonard BE; Neuhoff V; Tonge SR Z Naturforsch C Biosci; 1974; 29(3):184-6. PubMed ID: 4276700 [No Abstract] [Full Text] [Related]
40. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes. Watson M; Roeske WR; Yamamura HI J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]